瘤性免疫病毒疗法:在抗病毒禾中找到瘤抗原针
Benjamin L Kendall1,2, Richard G Vile1,2,3
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
Immunotherapy
|June 6, 2025
概括
免疫病毒疗法将瘤病毒 (OV) 与免疫检查点阻塞 (ICB) 结合起来,以增强抗瘤免疫力. 添加瘤相关抗原 (TAA) 优化了这种三方方法,以获得更好的癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 免疫病毒疗法利用瘤病毒 (OV) 诱导瘤细胞溶解和炎症,理论上与免疫检查点阻塞 (ICB) 协同作用.
- 有限的临床数据证实了OV和ICB的协同作用,部分原因是病毒免疫主导阻碍了抗瘤T细胞反应.
研究的目的:
- 审查免疫病毒治疗的范式,专注于抗病毒炎症和瘤相关抗原 (TAAs).
- 探索使用OV,ICB和TAA用于固体瘤治疗的组合策略.
主要方法:
- 基本免疫病毒疗法原则的剖析.
- 对结合策略的临床前和临床数据的审查.
主要成果:
- 病毒免疫主导性可以限制抗瘤T细胞的原始化和有效性.
- 结合TAA可以同步抗病毒和抗瘤T细胞扩张,以改善ICB治疗.
结论:
- 结合OVs,ICB和TAAs的三方方法显示出增强抗瘤T细胞反应的希望.
- 这种策略利用抗病毒免疫力在体内扩大亚主导的抗瘤T细胞,用于固体瘤治疗.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Immune Response Against Viral Pathogens
938
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
938
Cancer Vaccines
522
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K


